BindingDB logo
myBDB logout

BDBM50250402 CHEMBL4084835

SMILES: NC(=N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(CCCc2ccc(F)cc2F)C(=O)[C@H]2CCCN2C1=O

InChI Key: InChIKey=JESKWCVDAANLJE-KCNPKYBPSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50250402   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
C-X-C chemokine receptor type 7 (CXCR7)


(Homo sapiens (Human))
BDBM50250402
PNG
(CHEMBL4084835)
Show SMILES NC(=N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(CCCc2ccc(F)cc2F)C(=O)[C@H]2CCCN2C1=O |r|
Show InChI InChI=1S/C53H59F2N11O6/c54-36-21-20-33(39(55)28-36)13-9-23-65-31-47(67)61-44(26-34-29-59-40-16-6-4-14-37(34)40)49(69)63-43(25-32-11-2-1-3-12-32)48(68)64-45(27-35-30-60-41-17-7-5-15-38(35)41)50(70)62-42(18-8-22-58-53(56)57)51(71)66-24-10-19-46(66)52(65)72/h1-7,11-12,14-17,20-21,28-30,42-46,59-60H,8-10,13,18-19,22-27,31H2,(H,61,67)(H,62,70)(H,63,69)(H,64,68)(H4,56,57,58)/t42-,43+,44-,45-,46+/m0/s1
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
7.90n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Modulation of ProLink-fused human CXCR7 expressed in CHOK1 cell membranes assessed as induction of EA-tagged beta-arrestin recruitment after 30 mins ...


J Med Chem 60: 9653-9663 (2017)


Article DOI: 10.1021/acs.jmedchem.7b01028
BindingDB Entry DOI: 10.7270/Q2ZG6VPQ
More data for this
Ligand-Target Pair
C-X-C chemokine receptor type 7


(Homo sapiens (Human))
BDBM50250402
PNG
(CHEMBL4084835)
Show SMILES NC(=N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(CCCc2ccc(F)cc2F)C(=O)[C@H]2CCCN2C1=O |r|
Show InChI InChI=1S/C53H59F2N11O6/c54-36-21-20-33(39(55)28-36)13-9-23-65-31-47(67)61-44(26-34-29-59-40-16-6-4-14-37(34)40)49(69)63-43(25-32-11-2-1-3-12-32)48(68)64-45(27-35-30-60-41-17-7-5-15-38(35)41)50(70)62-42(18-8-22-58-53(56)57)51(71)66-24-10-19-46(66)52(65)72/h1-7,11-12,14-17,20-21,28-30,42-46,59-60H,8-10,13,18-19,22-27,31H2,(H,61,67)(H,62,70)(H,63,69)(H,64,68)(H4,56,57,58)/t42-,43+,44-,45-,46+/m0/s1
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
8n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Displacement of [125I]-CXCL12 from human CXCR7 expressed in CHOK1 cell membranes after 2 hrs by scintillation counting method


J Med Chem 60: 9653-9663 (2017)


Article DOI: 10.1021/acs.jmedchem.7b01028
BindingDB Entry DOI: 10.7270/Q2ZG6VPQ
More data for this
Ligand-Target Pair